{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:25:28Z","timestamp":1788323128086,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,6,9]],"date-time":"2018-06-09T00:00:00Z","timestamp":1528502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10787-018-0498-5","type":"journal-article","created":{"date-parts":[[2018,6,9]],"date-time":"2018-06-09T09:49:27Z","timestamp":1528537767000},"page":"1141-1149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article"],"prefix":"10.1007","volume":"26","author":[{"given":"Annamaria","family":"Mascolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale Maria","family":"Berrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Gareri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Capuano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Manzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liberato","family":"Berrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,9]]},"reference":[{"key":"498_CR1","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1136\/ard.2006.068676","volume":"66","author":"GS Alarcon","year":"2007","unstructured":"Alarcon GS, McGwin G, Bertoli AM et al (2007) Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from Lumina, a multiethnic US cohort (Lumina L). Ann Rheum Dis 66:1168\u20131172","journal-title":"Ann Rheum Dis"},{"key":"498_CR2","first-page":"369","volume":"28","author":"E Altintas","year":"2015","unstructured":"Altintas E (2015) Hydroxychloraquine-induced acute psychotic disorder in a female patient with rheumatoid arthritis: a case report. D\u00fc\u015f\u00fcnen Adam J Psychiatry Neurol Sci 28:369\u2013373","journal-title":"D\u00fc\u015f\u00fcnen Adam J Psychiatry Neurol Sci"},{"key":"498_CR3","first-page":"588","volume":"27","author":"JF Amp\u00e9las","year":"2001","unstructured":"Amp\u00e9las JF, Wattiaux MJ, Van Amerongen AP (2001) Psychiatric manifestations of lupus erythematosus systemic and Sjogren\u2019s syndrome. Encephale 27:588\u2013599","journal-title":"Encephale"},{"key":"498_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2165\/11598550-000000000-00000","volume":"29","author":"L Arnaud","year":"2012","unstructured":"Arnaud L, Mathian A, Boddaert J et al (2012) Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment. Drugs Aging 29:181\u2013189","journal-title":"Drugs Aging"},{"key":"498_CR5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/0961203313513818","volume":"23","author":"J Bogaczewicz","year":"2014","unstructured":"Bogaczewicz J, Sob\u00f3w T, Bogaczewicz A et al (2014) Exacerbations of bipolar disorder triggered by chloroquine in systemic lupus erythematosus\u2014a case report. Lupus 23:188\u2013193","journal-title":"Lupus"},{"key":"498_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1056\/NEJM199101173240303","volume":"324","author":"Canadian Hydroxychloroquine Study Group","year":"1991","unstructured":"Canadian Hydroxychloroquine Study Group (1991) A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med 324:150\u2013154","journal-title":"N Engl J Med"},{"key":"498_CR7","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1192\/bjp.bp.111.092098","volume":"200","author":"SJ Chen","year":"2012","unstructured":"Chen SJ, Chao YL, Chen CY et al (2012) Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study. Br J Psychiatry 200:374\u2013380","journal-title":"Br J Psychiatry"},{"key":"498_CR8","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1111\/1756-185X.13013","volume":"67","author":"IA Choi","year":"2017","unstructured":"Choi IA, Park SH, Cha HS et al (2017) Prevalence of co-morbidities and evaluation of their monitoring in Korean patients with rheumatoid arthritis: comparison with the results of an international, cross-sectional study (COMORA). Int J Rheum Dis 67:1939\u20131940. \n                    https:\/\/doi.org\/10.1111\/1756-185X.13013\n                    \n                   ([Epub ahead of print])","journal-title":"Int J Rheum Dis"},{"key":"498_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12016-015-8469-8","volume":"49","author":"N Costedoat-Chalumeau","year":"2015","unstructured":"Costedoat-Chalumeau N, Dunogu\u00e9 B et al (2015) A critical review of the effects of hydroxychloroquine and chloroquine on the eye. Clin Rev Allergy Immunol 49:317\u2013326","journal-title":"Clin Rev Allergy Immunol"},{"key":"498_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/bmb\/ldm016","volume":"83","author":"KM Cresswell","year":"2007","unstructured":"Cresswell KM, Fernando B, McKinstry B et al (2007) Adverse drug events in the elderly. Br Med Bull 83:259\u2013274","journal-title":"Br Med Bull"},{"key":"498_CR11","doi-asserted-by":"publisher","first-page":"766","DOI":"10.6061\/clinics\/2013(06)07","volume":"68","author":"JC Silva Da","year":"2013","unstructured":"Da Silva JC, Mariz HA, da Rocha J\u00fanior LF et al (2013) Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients. Clinics 68:766\u2013771","journal-title":"Clinics"},{"key":"498_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.psym.2013.06.017","volume":"55","author":"P Das","year":"2014","unstructured":"Das P, Rai A, Chopra A et al (2014) Psychosis likely induced by hydroxychloroquine in a patient with chronic Q fever: a case report and clinically relevant review of pharmacology. Psychosomatics 55:409\u2013413","journal-title":"Psychosomatics"},{"key":"498_CR13","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.comppsych.2013.05.010","volume":"54","author":"Pinho Oliveira de","year":"2013","unstructured":"de Oliveira Pinho, Ribeiro N, de Mello Rafael, Schier A, Ornelas AC et al (2013) Anxiety, depression and suicidal ideation in patients with rheumatoid arthritis in use of methotrexate, hydroxychloroquine, leflunomide and biological drugs. Compr Psychiatry 54:1185\u20131189","journal-title":"Compr Psychiatry"},{"key":"498_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1055\/s-2002-34114","volume":"35","author":"A Dietz","year":"2002","unstructured":"Dietz A, Frolich L (2002) Mefloquine-induced paranoid psychosis and subsequent major depression in a 25-year-old student. Pharmacopsychiatry 35:200\u2013202","journal-title":"Pharmacopsychiatry"},{"key":"498_CR15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1176\/appi.ajp.163.3.521","volume":"163","author":"WW Eaton","year":"2006","unstructured":"Eaton WW, Byrne M, Ewald H et al (2006) Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry 163:521\u2013528","journal-title":"Am J Psychiatry"},{"key":"498_CR16","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0151-9638(04)93642-3","volume":"131","author":"V Ferraro","year":"2004","unstructured":"Ferraro V, Mantoux F, Denis K et al (2004) Hallucinations during treatment with hydrochloroquine. Ann Dermatol Venereol 131:471\u2013473 (French)","journal-title":"Ann Dermatol Venereol"},{"key":"498_CR17","unstructured":"Food and Drug Administration (2013) Drug safety communication: FDA approves label changes for antimalarial drug mefloquine hydrochloride due to risk of serious psychiatric and nerve side effects. FDA website. \n                    https:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM362232.pdf\n                    \n                  . Accessed 05 April 2018"},{"key":"498_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0049-0172(10)80012-5","volume":"23","author":"RI Fox","year":"1993","unstructured":"Fox RI (1993) Mechanism of action of hydroxychloroquine as an antirheumatic drug. Semin Arthr Rheum 23:82\u201391","journal-title":"Semin Arthr Rheum"},{"key":"498_CR19","first-page":"98","volume-title":"Farmacologia clinica reumatologica","author":"A Giacomello","year":"1987","unstructured":"Giacomello A (1987) Synthetic antimalarials derived from 4-aminoquinoline. In: D\u2019Elia S, D\u2019Erasmo E, Giacomello A et al (eds) Farmacologia clinica reumatologica. Masson ed., Milan, pp 98\u201399"},{"key":"498_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1177\/0961203314558863","volume":"24","author":"JA Gonzalez-Nieto","year":"2015","unstructured":"Gonzalez-Nieto JA, Costa-Juan E (2015) Psychiatric symptoms induced by hydroxychloroquine. Lupus 24:339\u2013340","journal-title":"Lupus"},{"key":"498_CR21","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1176\/ajp.134.5.601","volume":"134","author":"MI Good","year":"1977","unstructured":"Good MI, Shader RI (1977) Behavioral toxicity and equivocal suicide associated with chloroquine and its derivatives. Am J Psychiatry 134:601\u2013798","journal-title":"Am J Psychiatry"},{"key":"498_CR22","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1601-5215.2011.00575.x","volume":"23","author":"W Hsu","year":"2011","unstructured":"Hsu W, Chiu N, Huang S (2011) Hydroxychloroquine-induced acute psychosis in a systemic lupus erythematosus female. Acta Neuropsychiatr 23:318\u2013319","journal-title":"Acta Neuropsychiatr"},{"key":"498_CR23","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.autrev.2015.07.015","volume":"14","author":"AF Joaquim","year":"2015","unstructured":"Joaquim AF, Appenzeller S (2015) Neuropsychiatric manifestations in rheumatoid arthritis. Autoimmun Rev 14:1116\u20131122","journal-title":"Autoimmun Rev"},{"key":"498_CR24","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1176\/appi.psy.44.4.339","volume":"44","author":"O Kukoyi","year":"2003","unstructured":"Kukoyi O, Carney CP (2003) Curses, madness, and mefloquine. Psychosomatics 44:339\u2013341","journal-title":"Psychosomatics"},{"key":"498_CR25","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/ncprheum0292","volume":"2","author":"D Kyburz","year":"2006","unstructured":"Kyburz D, Brentano F, Gay S (2006) Mode of action of hydroxychloroquine in RA-evidence of an inhibitory effect on toll-like receptor signaling. Nat Clin Pract Rheumatol 2:458\u2013459","journal-title":"Nat Clin Pract Rheumatol"},{"key":"498_CR26","first-page":"685","volume-title":"Geriatria nel territorio","author":"C Manzo","year":"2012","unstructured":"Manzo C (2012) Rheumatologic concerns in an elderly patient. In: Putignano S, Cester A, Gareri P (eds) Geriatria nel territorio. Critical Medicine Publishing, Rome, pp 685\u2013691"},{"key":"498_CR27","first-page":"287","volume":"63","author":"C Manzo","year":"2015","unstructured":"Manzo C, Esposito C, Putignano S et al (2015) Systemic lupus erythematosus in a centenarian woman, presenting as serositis with fever. G Gerontol 63:287\u2013289","journal-title":"G Gerontol"},{"key":"498_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s40800-017-0048-x","volume":"4","author":"C Manzo","year":"2017","unstructured":"Manzo C, Gareri P, Castagna A (2017) Psychomotor agitation following treatment with hydroxychloroquine. Drug Saf Case Rep 4:6","journal-title":"Drug Saf Case Rep"},{"key":"498_CR29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/rheumatology\/33.3.235","volume":"33","author":"AJ McLachlan","year":"1994","unstructured":"McLachlan AJ, Tett SE, Cutler DJ et al (1994) Bioavailability of hydroxychloroquine tablets in patients with rheumatoid arthritis. Br J Rheumatol 33:235\u2013239","journal-title":"Br J Rheumatol"},{"key":"498_CR30","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1191\/0961203302lu203ra","volume":"11","author":"Y Molad","year":"2002","unstructured":"Molad Y, Gorshtein A, Wysenbeek AJ et al (2002) Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort. Lupus 11:356\u2013361","journal-title":"Lupus"},{"key":"498_CR31","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1073\/pnas.75.7.3327","volume":"75","author":"S Ohkuma","year":"1978","unstructured":"Ohkuma S, Poole B (1978) Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci USA 75:3327\u20133331","journal-title":"Proc Natl Acad Sci USA"},{"key":"498_CR32","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0140-6736(51)91643-1","volume":"2","author":"F Page","year":"1951","unstructured":"Page F (1951) Treatment of lupus erythematosus with mepacrine. Lancet 2:755\u2013758","journal-title":"Lancet"},{"key":"498_CR33","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1177\/0961203396005001051","volume":"5","author":"M Petri","year":"1996","unstructured":"Petri M (1996) Hydroxychloroquine use in the baltimore lupus cohort: effects on lipids, glucose and thrombosis. Lupus 5:S16\u2013S22","journal-title":"Lupus"},{"key":"498_CR34","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S0196-0644(96)70206-8","volume":"27","author":"RB Piening","year":"1996","unstructured":"Piening RB, Young SA (1996) Mefloquine-induced psychosis. Ann Emerg Med 27:792\u2013793","journal-title":"Ann Emerg Med"},{"key":"498_CR35","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10787-015-0239-y","volume":"23","author":"KD Rainsford","year":"2015","unstructured":"Rainsford KD, Parke AL, Clifford-Rashotte M et al (2015) Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases. Inflammopharmacology 23:231\u2013269","journal-title":"Inflammopharmacology"},{"key":"498_CR36","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1056\/NEJMoa035471","volume":"349","author":"MJ Roman","year":"2003","unstructured":"Roman MJ, Shanker BA, Davis A et al (2003) Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349:2399\u20132406","journal-title":"N Engl J Med"},{"key":"498_CR37","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1177\/0961203306071872","volume":"15","author":"G Ruiz-Irastorza","year":"2006","unstructured":"Ruiz-Irastorza G, Egurbide MV, Pijoan JI et al (2006) Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. Lupus 15:577\u2013583","journal-title":"Lupus"},{"key":"498_CR38","first-page":"864","volume-title":"Textbook of Rheumatology","author":"RI Rynes","year":"2001","unstructured":"Rynes RI (2001) Antimalarials. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of Rheumatology. Saunders Company, London, United Kingdom, pp 864\u2013865"},{"key":"498_CR39","unstructured":"SANOFI SPA (2016) Plaquenil 200\u00a0mg summary of product characteristics. Italian medicine agency website. \n                    https:\/\/farmaci.agenziafarmaco.gov.it\/aifa\/servlet\/PdfDownloadServlet?pdfFileName=footer_008055_013967_RCP.pdf&retry=0&sys=m0b1l3\n                    \n                  . Accessed 02 April 2018"},{"key":"498_CR40","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1345\/aph.1E409","volume":"39","author":"DS Telgt","year":"2005","unstructured":"Telgt DS, van der Ven AJ, Schimmer B et al (2005) Serious psychiatric symptoms after chloroquine treatment following experimental malaria infection. Ann Pharmacother 39:551\u2013554","journal-title":"Ann Pharmacother"},{"key":"498_CR41","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1365-2125.1989.tb03439.x","volume":"27","author":"SE Tett","year":"1989","unstructured":"Tett SE, Cutler DJ, Day RO et al (1989) Bioavailability of hydroxychloroquine tablets in healthy volunteers. Br J Clin Pharmacol 27:771\u2013779","journal-title":"Br J Clin Pharmacol"},{"key":"498_CR42","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S0190-9622(85)70109-0","volume":"12","author":"WQ Ward","year":"1985","unstructured":"Ward WQ, Walter-Ryan WG, Shehi GM (1985) Toxic psychosis: a complication of antimalarial therapy. J Am Acad Dermatol 12:863\u2013865","journal-title":"J Am Acad Dermatol"},{"key":"498_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1001\/jama.298.2.187","volume":"298","author":"MC Wasko","year":"2007","unstructured":"Wasko MC, Hubert HB, Lingala VB et al (2007) Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. JAMA 298:187\u2013193","journal-title":"JAMA"},{"key":"498_CR44","first-page":"1124","volume":"159","author":"A Wozniacka","year":"2008","unstructured":"Wozniacka A, Lesiak A, Boncela J, Smolarczyk K, McCauliffe DP, Sysa-Jedrzejowska A (2008) The influence of antimalarial treatment on IL-1beta, IL-6 and TNF-alpha mRNA expression on UVB-irradiated skin in systemic lupus erythematosus. Br J Dermatol 159:1124\u20131130","journal-title":"Br J Dermatol"},{"key":"498_CR45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1073\/pnas.79.1.175","volume":"79","author":"HK Ziegler","year":"1982","unstructured":"Ziegler HK, Unanue ER (1982) Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci USA 79:175\u2013178","journal-title":"Proc Natl Acad Sci USA"},{"key":"498_CR46","first-page":"157","volume":"13","author":"AA Zulfiqar","year":"2015","unstructured":"Zulfiqar AA, Courtel T, Novella JL et al (2015) Late-onset lupus in the elderly after 65\u00a0years: retrospective study of 18 cases. Geriatr Psychol Neuropsychiatr Vieil 13:157\u2013168 (French)","journal-title":"Geriatr Psychol Neuropsychiatr Vieil"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-018-0498-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-018-0498-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-018-0498-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T19:16:26Z","timestamp":1560021386000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-018-0498-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,9]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["498"],"URL":"https:\/\/doi.org\/10.1007\/s10787-018-0498-5","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,9]]},"assertion":[{"value":"9 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}